Free for academic non-profit institutions. Other users need a Commercial license
Catechol-O-methyltransferase catalyzes the transfer of a methyl group from S-adenosylmethionine to catecholamines, including the neurotransmitters dopamine, epinephrine, and norepinephrine. This O-methylation results in one of the major degradative pathways of the catecholamine transmitters. In addition to its role in the metabolism of endogenous substances, COMT is important in the metabolism of catechol drugs used in the treatment of hypertension, asthma, and Parkinson disease. COMT is found in two forms in tissues, a soluble form (S-COMT) and a membrane-bound form (MB-COMT). The differences between S-COMT and MB-COMT reside within the N-termini. Several transcript variants are formed through the use of alternative translation initiation sites and promoters. [provided by RefSeq, Sep 2008]
COMT (Catechol-O-Methyltransferase) is a Protein Coding gene. Diseases associated with COMT include Schizophrenia and Panic Disorder 1. Among its related pathways are Neuroscience and Transmission across Chemical Synapses. Gene Ontology (GO) annotations related to this gene include magnesium ion binding and catechol O-methyltransferase activity. An important paralog of this gene is LRTOMT.
Catechol O-Methyltransferase (COMT) (EC 2.1.1.6) catalyzes the transfer of a methyl group from S-adenosyl-L-methionine (AdoMet) to a catechol substrate, such as dopamine or levodopa, in the presence of magnesium (Mg2+) ions.
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0000287 | magnesium ion binding | IEA | -- |
GO:0005515 | protein binding | IPI | 16189514 |
GO:0008168 | methyltransferase activity | TAS | -- |
GO:0008171 | O-methyltransferase activity | IEA,IBA | 21873635 |
GO:0016206 | catechol O-methyltransferase activity | TAS | -- |
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0005737 | cytoplasm | IEA | -- |
GO:0005829 | cytosol | TAS | -- |
GO:0005886 | plasma membrane | TAS | -- |
GO:0016020 | membrane | IBA | 21873635 |
GO:0016021 | integral component of membrane | IEA | -- |
SuperPathway | Contained pathways | ||
---|---|---|---|
1 | Cytochrome P450 - arranged by substrate type |
.01
Estradiol metabolism
.01
|
|
2 | Neurotransmitter Clearance In The Synaptic Cleft | ||
3 | noradrenaline and adrenaline degradation | ||
4 | Metabolism |
.40
|
|
5 | Tyrosine metabolism |
Tyrosine metabolism p.1 (dopamine)
.32
|
GO ID | Qualified GO term | Evidence | PubMed IDs |
---|---|---|---|
GO:0006584 | catecholamine metabolic process | IEA | -- |
GO:0007565 | female pregnancy | IEA | -- |
GO:0007612 | learning | IEA | -- |
GO:0007614 | short-term memory | IEA | -- |
GO:0008210 | estrogen metabolic process | IEA | -- |
Name | Status | Disease Links | Group | Role | Mechanism of Action | Clinical Trials |
---|---|---|---|---|---|---|
Entacapone | Approved, Investigational | Pharma | Target, Enzyme, inhibitor | COMT inhibitor, Potent COMT inhibitor; blocks alpha-synuclein aggregation | 56 | |
Tolcapone | Approved, Withdrawn | Pharma | Target, inhibitor | COMT inhibitor, COMT inhibitor; also inhibits transthyretin aggregation | 25 | |
Dopamine | Approved | Pharma | Agonist, Full agonist, Enzyme, substrate | 3978 | ||
Morphine | Approved, Investigational | Pharma | Agonist, Full agonist, Partial agonist | 1406 | ||
Epinephrine | Approved, Vet_approved | Pharma | Enzyme, substrate | 1364 |
Name | Synonyms | Role | CAS Number | PubChem IDs | PubMed IDs | |
---|---|---|---|---|---|---|
2-hydroxyestrone |
|
362-06-1 | ||||
3-methoxytyramine |
|
554-52-9 | ||||
Homovanillic acid |
|
306-08-1 | ||||
Metanephrine |
|
5001-33-2 | ||||
Normetanephrine |
|
97-31-4 |
Compound | Action | Cas Number |
---|---|---|
Entacapone | Potent COMT inhibitor; blocks alpha-synuclein aggregation | 130929-57-6 |
OR-486 | Catechol O-methyltransferase inhibitor | 7659-29-2 |
Tolcapone | COMT inhibitor; also inhibits transthyretin aggregation | 134308-13-7 |
Compound | Action | Cas Number |
---|---|---|
Entacapone | COMT inhibitor | 130929-57-6 |
Entacapone sodium salt | COMT inhibitor | 1047659-02-8 |
OR-486 | 7659-29-2 | |
Tolcapone | COMT inhibitor | 134308-13-7 |
ExUns: | 1 | ^ | 2 | ^ | 3a | · | 3b | ^ | 4a | · | 4b | ^ | 5a | · | 5b | ^ | 6a | · | 6b | ^ | 7a | · | 7b | · | 7c | ^ | 8a | · | 8b | ^ | 9 | ^ | 10a | · | 10b |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
SP1: | - | - | - | - | - | - | - | - | |||||||||||||||||||||||||||
SP2: | - | ||||||||||||||||||||||||||||||||||
SP3: | - | - | |||||||||||||||||||||||||||||||||
SP4: | - | - | - | ||||||||||||||||||||||||||||||||
SP5: | - | ||||||||||||||||||||||||||||||||||
SP6: | - | ||||||||||||||||||||||||||||||||||
SP7: | - | - | - | - | |||||||||||||||||||||||||||||||
SP8: | - | - | - |
This gene was present in the common ancestor of animals and fungi.
Organism | Taxonomy | Gene | Similarity | Type | Details |
---|---|---|---|---|---|
Chimpanzee (Pan troglodytes) |
Mammalia | COMT 30 31 |
|
OneToOne | |
Dog (Canis familiaris) |
Mammalia | COMT 30 31 |
|
OneToOne | |
Cow (Bos Taurus) |
Mammalia | COMT 30 31 |
|
OneToOne | |
Rat (Rattus norvegicus) |
Mammalia | Comt 30 |
|
||
Mouse (Mus musculus) |
Mammalia | Comt 30 17 31 |
|
OneToOne | |
Oppossum (Monodelphis domestica) |
Mammalia | COMT 31 |
|
OneToOne | |
Platypus (Ornithorhynchus anatinus) |
Mammalia | COMT 31 |
|
OneToOne | |
Chicken (Gallus gallus) |
Aves | COMT 30 31 |
|
OneToOne | |
Tropical Clawed Frog (Silurana tropicalis) |
Amphibia | comt 30 |
|
||
African clawed frog (Xenopus laevis) |
Amphibia | Xl.15713 30 |
|
||
Zebrafish (Danio rerio) |
Actinopterygii | comta 31 |
|
OneToMany | |
Fission Yeast (Schizosaccharomyces pombe) |
Schizosaccharomycetes | SPBC119.03 30 |
|
||
Bread mold (Neurospora crassa) |
Ascomycetes | NCU07919 30 |
|
||
Sea Squirt (Ciona savignyi) |
Ascidiacea | -- 31 |
|
OneToOne |
SNP ID | Clinical significance and condition | Chr 22 pos | Variation | AA Info | Type |
---|---|---|---|---|---|
678640 | Benign: not provided | 19,942,028(+) | A/G | INTRON_VARIANT | |
678642 | Likely Benign: not provided | 19,941,996(+) | G/A | INTRON_VARIANT | |
717115 | Benign: not provided | 19,962,643(+) | C/T | SYNONYMOUS_VARIANT,FIVE_PRIME_UTR_VARIANT | |
722444 | Benign: not provided | 19,962,824(+) | C/T | INTRON_VARIANT | |
726010 | Likely Benign: not provided | 19,964,188(+) | G/A | SYNONYMOUS_VARIANT |
Variant ID | Type | Subtype | PubMed ID |
---|---|---|---|
dgv72n68 | CNV | loss | 17160897 |
dgv7983n54 | CNV | gain | 21841781 |
esv1007918 | CNV | deletion | 20482838 |
esv1009031 | CNV | deletion | 20482838 |
esv1291604 | CNV | deletion | 17803354 |
esv3568270 | CNV | loss | 25503493 |
esv3568271 | CNV | loss | 25503493 |
esv3575418 | CNV | gain | 25503493 |
esv3584493 | CNV | gain | 24956385 |
esv3647280 | CNV | gain | 21293372 |
esv3893434 | CNV | gain | 25118596 |
nsv1055752 | CNV | gain | 25217958 |
nsv1064496 | CNV | gain | 25217958 |
nsv1071776 | CNV | deletion | 25765185 |
nsv1136656 | CNV | deletion | 24896259 |
nsv469641 | CNV | loss | 16826518 |
nsv517165 | CNV | loss | 19592680 |
nsv588238 | CNV | loss | 21841781 |
nsv588240 | CNV | loss | 21841781 |
nsv828938 | CNV | gain | 20364138 |
nsv828939 | CNV | loss | 20364138 |
nsv953026 | CNV | deletion | 24416366 |
Disorder | Aliases | PubMed IDs |
---|---|---|
schizophrenia |
|
|
panic disorder 1 |
|
|
psychotic disorder |
|
|
schizotypal personality disorder |
|
|
paranoid schizophrenia |
|